Newsfeeds Archive - Page 4 of 7

2 minute read

Three In A Row: FibroGen’s Investigational Drug Flunks In Another Study For Rare Disease In Young Boys

August 30, 7:42 AM

Tuesday, FibroGen Inc (NASDAQ: FGEN) announced topline data from the Phase 3 LELANTOS-2 trial of pamrevlumab for ambulatory patients with Duchenne muscular dystrophy (DMD) on

FGEN

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s After-Market Session

By Benzinga Insights

August 29, 5:31 PM

Gainers Axcella Health (NASDAQ:AXLA) stock rose 14.4% to $0.52 during Tuesday’s after-market session. Axcella Health’s trading volume hit…

AEON

11 minute read

Options

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

August 9, 12:27 PM

On Wednesday, 155 companies set new 52-week lows.

ABVC

1 minute read

Earnings

Preview: FibroGen’s Earnings

By Benzinga Insights

August 4, 11:04 AM

FibroGen (NASDAQ:FGEN) is set to give its latest quarterly earnings report on Monday, 2023-08-07. Here’s what investors need…

FGEN

5 minute read

Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

July 27, 12:17 PM

During Thursday, 56 stocks hit new 52-week lows.

ABVC

5 minute read

Options

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

July 26, 12:18 PM

Wednesday saw 59 companies set new 52-week lows.

ACGN

5 minute read

Options

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

July 24, 3:48 PM

On Monday morning, 70 companies achieved new lows for the year.

ADCT

4 minute read

Options

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

July 21, 1:24 PM

On Friday, 54 companies hit new 52-week lows.

ACGN

3 minute read

Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

July 20, 2:01 PM

During Thursday's session, 40 stocks hit new 52-week lows.

ACGN

2 minute read

Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month

By Lisa Levin

July 18, 8:54 AM

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

AADI